Question 1

What are the most cited papers from Immunitor (Mongolia)?

Accepted Answer

The most cited paper from Immunitor (Mongolia) is "Phase III, placebo-controlled, randomized, double-blind trial of tableted, therapeutic TB vaccine (V7) containing heat-killed M. vaccae administered daily for one month" (Aldar S. Bourinbaiar et al., 2019), with 32 citations. Next come "Randomized, placebo-controlled phase II trial of heat-killedMycobacterium vaccae(Longcom batch) formulated as an oral pill (V7)" (28) and "Effect of pneumococcal conjugate vaccination on pneumococcal carriage in hospitalised children aged 2–59 months in Mongolia: an active pneumonia surveillance programme" (16).

Question 2

Which research topics does Immunitor (Mongolia) publish most on?

Accepted Answer

By volume in 2022-now: Reproductive Biology and Fertility, Assisted Reproductive Technology and Twin Pregnancy, Ovarian function and disorders and Respiratory viral infections research.

Question 3

Which fields of science does Immunitor (Mongolia) work in?

Accepted Answer

In all years, 71% of research at Immunitor (Mongolia) is in Health Sciences, 18% in Physical Sciences. Its largest fields are Medicine (71%), Environmental Science (12%), Agricultural and Biological Sciences (6%).

Question 4

Is Immunitor (Mongolia)'s research output growing?

Accepted Answer

Output in 2022-2025 was 15% higher than in 2018-2021.